C]lactate as a useful substrate for assessing redox levels in the liver in vivo. Methods: Animal experiments were conducted to measure in vivo metabolism at baseline and after ethanol infusion. A solution of 80-mM hyperpolarized [1-
INTRODUCTION
Nicotinamide adenine dinucleotide (NAD þ ) and its reduced form (NADH) are essential coenzymes involved in several vital biochemical reactions controlling cellular redox states in two fundamental cellular compartments: cytoplasm and mitochondria. Unlike the protein-bound NAD þ and NADH, the ratio of the concentration of free NAD þ and NADH reflects intracellular redox states. Growing evidence has indicated that altered redox and associated oxidative stress are implicated in the etiology of multiple pathological conditions such as cancer (1, 2) , diabetes (3, 4) , neurodegenerative diseases (5) , and inflammatory processes (6) . Moreover, the redox plays a fundamental role in cell survivals (7, 8) and cellular signaling (9) and is closely related to the regulation of embryonic stem cell development (10) and aging (11) .
Conventionally, two types of methods are used to measure free cellular [ (14) . The accuracy of these measurements depends on the stability of intercellular pH, which, for most cases, is a relatively safe assumption (15, 16) . These chemical methods, however, require cell extraction and thus cannot be used for in vivo studies. The ratio of carbon-13 ( 13 C)-labeled lactate and pyruvate, as measured by magnetic resonance spectroscopy (MRS) (17) after administration of 13 C-labeled glucose, allows noninvasive in vivo assessment of redox state (reflecting the intrinsic pool sizes of endogenous lactate and pyruvate) but has low sensitivity, and the long measurement times increase sensitivity to potential metabolic perturbations from the 13 C-labeled substrate.
Hyperpolarized

13
C-substrate using dynamic nuclear polarization (DNP) in combination with a rapid dissolution technique immediately followed by MRS signal acquisition permits a rapid assessment of enzymatic activities in multiple metabolic pathways in vivo with an unprecedented amplification of the MR signals (18) . In particular, pyruvate has been the most successful substrate to date for DNP because of its central role connecting multiple cellular metabolic pathways in addition to high polarization and relatively long longitudinal relaxation time (T 1 ). Although the 13 C-lactate to 13 C-pyruvate ratio derived from injected hyperpolarized 13 C-pyruvate may reflect cellular redox state to some extent (19, 20) , it does not provide an accurate measure because much of the 13 C-pyruvate signal comes from the vasculature and a significant lactate is also produced in extracellular space (Fig. 1a) C-glucose and showed large variations in cytosolic redox in different cancer cells (23) . The method provides the quantitative cytosolic redox state, but hyperpolarized 13 C-glucose suffers a significantly short T 1 even with deuteration and needs to pass through multiple metabolic steps to produce pyruvate and lactate, resulting in low signal-to-noise ratio (SNR) and therefore limitation in in vivo studies.
In this study, we assessed a quantitative method to measure cytosolic redox state in the rat liver using hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine. Hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine, which is readily transported across the plasma membrane (24) , is useful to measure intracellular redox because the level of alanine transaminase (ALT) in the serum is negligible, resulting in almost all 13 C-pyruvate and (Fig. 1b) (25) . We demonstrate the feasibility of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine to measure in vivo liver redox in both baseline conditions and postethanol-induced redox changes.
METHODS
Hardware and Animal Preparation
All MR measurements were performed on a clinical 3T GE Signa PET/MR scanner (GE Healthcare, Waukesha, Wisconsin, USA). Eight healthy male Wistar rats (body weight, 365-453 g) were prepared for the experiments. Each animal was anesthetized with 2%-3% isoflurane in oxygen ($1.5 L/min) and catheterized into the tail vein before placing at the center of the MR bore. A custom-built 13 C surface coil (single loop, Ø ¼ 28 mm) was placed over the liver for both radiofrequency excitation and signal acquisition. Animal vital signs were monitored throughout the experiments; respiratory rate was maintained at the levels of 50-60 breaths/min by adjusting isoflurane level (26) and body temperature was regulated at 36 C-36.5 C using a warm water blanket placed underneath the animals. All procedures were approved by the local Institutional Animal Care and Use Committee.
Substrate and Dynamic Nuclear Polarization
Hyperpolarization of the [1- 13 C]alanine was performed using a SPINlab clinical DNP polarizer (GE Healthcare, Waukesha, Wisconsin, USA) equipped with a 5T magnet and operated with research fluid paths (GE Healthcare, Waukesha, Wisconsin, USA). The optimal microwave irradiation frequency for [1- 13 C]pyruvate (139.93 GHz) was used for [1- polarization to ensure the maximum polarization, the sample was dissolved and mixed with 250 mL of a buffer solution (a mixture of 6.1 mL of 121 mM HCl, 100 mg/L of disodium EDTA, 40 mM sodium phosphate buffer), resulting in a 7.5-mL solution of 80 mM [1- 13 C]alanine with a pH of 7.5. Independent hyperpolarized phantom experiments were performed to estimate liquid polarization level at the time of dissolution and T 1 of 13 C-labeled alanine (27) . A dose of 0.8 mmol/kg body weight of the [1- 13 C]alanine solution was administered 30 s after the dissolution through the tail vein catheter at a rate of 0.25 mL/s. Up to two alanine solutions were injected per animal. 13 C MRS data were acquired immediately after injection of the hyperpolarized compounds using the dynamic free induction decay sequence with a 10 hard radiofrequency pulse (pulse width ¼ 40 ms; spectral width ¼ 5000 Hz; 2048 spectral points; acquisition time ¼ 4 min; temporal resolution ¼ 3 s). Data from the time-resolved spectroscopy were apodized by a 10-Hz Gaussian filter followed by zero filling by a factor of four and a fast Fourier transform using MATLAB (MathWorks, Natick, Massachusetts, USA). Metabolites were quantified by integrating the respective peak in the absorption mode after zero-order phase correction. For spectral display, the baseline roll was subtracted by fitting a spline to the signal-free regions of the smoothed spectrum.
Data Acquisition and Reconstruction
All
Tissue redox state was calculated from the measured ratio of 13 C-lactate and 13 C-pyruvate signals using the equation
where the cytosolic pH was assumed as 7.0 and K eq is 1.11 Â 10 À11 M (14).
Intracellular Redox Status Modulation Using Ethanol
Hepatic metabolism of ethanol results in the production of large amount of cytosolic and mitochondrial NADH leading to alternations in the normal hepatic redox state.
To induce a hepatic redox change (28), 1 mL/kg of 20% ethanol was infused intravenously at a rate of 1 mL/min to achieve a targeted steady-state blood alcohol level of approximately 100 mg/dL at the time of the second acquisition using hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine (45 min after ethanol infusion) (20) . The altered redox was also calculated using Equation 2 with an assumption of reestablishing equilibrium after ethanol infusion (29) .
Quantification of 13 C-Enriched Lactate in Blood by High-Resolution Proton NMR Spectroscopy
A 1-mL blood sample was collected from separate control (body weight, 509-513 g; n ¼ 3) and ethanol-treated (body weight, 429-508 g; n ¼ 3) rats before and 1 min after a bolus injection of 80 mM [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine. Injection speed, volume, and dosages of alanine solution and ethanol were identical to the imaging studies. For the ethanol-treated group, the second blood samples were collected 45 min after the start of ethanol infusion. The whole blood samples were extracted with 5% perchloric acid. The extracts were then neutralized with potassium hydroxide, freeze-dried, and reconstituted in D 2 O containing 1-mM EDTA and 0.5-mM DSS-D 6 (Chenomx, Edmonton, Alberta, Canada) for 1 H NMR. High-resolution NMR spectra were acquired at 600 MHz (Bruker BioSpin, Billerica, Massachusetts, USA) equipped with a cryoprobe operating at 15 K. NMR spectra were processed using ACD/NMR Processor (ACD/Labs, Toronto, Canada).
Data Analysis
A paired Student t test with two-tailed analysis (a ¼ 0.05) was used for the rats (n ¼ 4) measured both at baseline and after ethanol infusion to assess significant differences in the metabolite ratios with and without ethanol. An additional two-sample t test with unequal sample sizes and variances (Welch's test) was performed for all measurements (a ¼ 0.05, two-tailed analysis, n ¼ 8 for baseline, n ¼ 4 for postethanol infusion). All values are reported as the mean 6 standard error. The SNR of each metabolite peak was calculated as the maximum of the peak divided by the standard deviation of the spectral noise.
RESULTS
In Vitro Polarization and T 1
Polarization of the [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine samples was measured as 13.9 6 1.1 (n ¼ 3) at the beginning of MR measurement (40-42 s after dissolution) and estimated as 24.8% 6 1.6% at the time of dissolution. In vitro T 1 of the hyperpolarized alanine was measured as 66.4 6 1.6 s at 3T, which is comparable to that of [1- 13 C]pyruvate. Due to the small sample volume and the large noise in the polarization monitoring from the SPINlab, the build-up time constant could not be estimated.
In Vivo Hyperpolarized [1-
13 C]Alanine Metabolism in Liver
As shown in a representative time-averaged (0-120 s) spectrum (Fig. 2a,b) , in vivo studies detected [1- C-labeled signals (tC), alanine was the dominant source of the signal, with smaller contributions from the lactate, pyruvate, and bicarbonate peaks (Table 1 ). The SNRs of metabolite peaks in the time-averaged spectra were 229.2 6 22.0 for lactate, 28.7 6 3.1 for pyruvate, and 20.2 6 2.2 for bicarbonate. The large intersubject difference in the product-to-tC ratios and the SNRs is probably due to the variations in the peripheral vascular contribution to the measured signal and the relative positions of the surface coil to the liver. 13 Clactate/ 13 C-pyruvate ratio was measured as 8.46 6 0.58 for the baseline (no ethanol) case. Although the temporal dynamics of lactate labeling were clearly observed, similar kinetics of pyruvate and bicarbonate were not reliably detected due to the SNR limitation of the time-resolved spectra (Fig. 2c) , and only the time-averaged spectra were used for further analysis.
In Vivo Assessment of Intracellular Redox State in Rat Liver
Metabolic Changes Due to Ethanol Infusion Figure 3 summarizes the changes in metabolic profile of hyperpolarized [1- 13 C]alanine in rat liver due to the additional metabolism of ethanol. As shown in representative time-averaged spectra (Fig. 3a,b) and time-courses of 13 C-labeled metabolites (Fig. 3c,d ), lactate labeling moderately increased (P ¼ 0.16, paired t test, n ¼ 4) whereas pyruvate (P ¼ 0.05) and bicarbonate (P ¼ 0.01) signals significantly decreased 45 min after ethanol infusion compared with baseline. In particular, the 13 Clactate/ 13 C-pyruvate ratio significantly increased to 13.58 6 0.69 after ethanol infusion (P ¼ 0.0008 for paired t test, n ¼ 4; P ¼ 0.0007 for Welch's test, n ¼ 8 for baseline and n ¼ 4 for postethanol infusion groups).
13 C-bicarbonate/ 13 C-pyruvate dropped significantly (P ¼ 0.005 for paired t test, P ¼ 0.007 for Welch's test). The results are summarized in Table 1 , and individual measurements of 13 Clactate/ 13 C-pyruvate and 13 C-bicarbonate/tC are shown in Figure 3e ,f. Figure 4 . Methyl proton resonances at 1.32 ppm and 1.47 ppm reflected the J HH spin-spin coupling in nonlabeled, endogenous lactate and alanine, respectively. After a bolus injection of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine, two sets of outer doublets were observed in the alanine resonance region reflecting the three-bond J CH spin-spin coupling between methyl protons and the 13 C at the carboxylate carbon. This confirms the dilution of the injected alanine into the circulating metabolite pool, as expected, in both control and ethanol-treated animals after the bolus injection. Similar outer doublets were not observed in the lactate resonance region, confirming that no circulating 13 C-enriched alanine was metabolized to pyruvate and subsequently lactate in the blood (Supporting Table S1 ).
H NMR Analysis of Alanine and Lactate in the Blood
DISCUSSION
C-Lactate-to-C-Pyruvate Ratio as a Biomarker for Cytosolic Redox State
In this study, we assessed the cytosolic redox state in rat liver in vivo using the C MRS metric is difficult due to the lack of an alternative method to measure redox in the living animal. Instead, we measured both absolute and changes in the rat liver 13 C-lactate/ 13 C-pyruvate ratio under baseline conditions and after ethanol infusion. In particular, our results show an acute increase in the 13 C-lactate/ 13 Cpyruvate ratio 45 min after ethanol injection. As shown in Figure 5 , we attribute this change to the elevated cytosolic NADH levels generated in the liver from the conversion of ethanol to acetaldehyde via alcohol dehydrogenase, 13 C-lactate increase was not significant (P ¼ 0.16, paired t-test; n ¼ 4), 13 C-pyruvate decreased significantly (P ¼ 0.05). (e, f) Changes in (e) 13 C-lactate to 13 C-pyruvate ratio and (f) 13 Cbicarbonate/tC were significant with both the paired t test (n ¼ 4) and the Welch's t test (n ¼ 8 for baseline, n ¼ 4 postethanol infusion).
FIG. 4. High-resolution
1 H NMR spectra in plasma. Blood serum was collected from control and ethanol-treated (45 min postethanol infusion) rats at baseline and 1 min after injection of 80 mM [1- 13 C]alanine. Whereas the alanine peaks showed additional quartets after the alanine injection due to the J CH coupling, the lactate peaks were comparable to the baseline measurement in both groups, suggesting that the increase of 13 C-lactate concentration in plasma at the time of measurement was not significant. All spectra were plotted at the same vertical scale using the peak intensity of DSS internal standard (0.5 mM DSS at 0 ppm) as a reference.
In Vivo Assessment of Intracellular Redox State in Rat Liver
assuming no other metabolic difference that affects lactate/ pyruvate ratio between the baseline and after ethanol infusion. The acetaldehyde is further oxidized to acetate in both the cytoplasm and mitochondria via aldehyde dehydrogenase 1 and 2, respectively, generating additional NADH in each cellular compartment (31) . The observed The use of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]alanine to measure intracellular 13 C-lactate/ 13 C-pyruvate can provide a robust noninvasive measure of tissue redox state, but only under the following conditions. First, the majority of lactate and pyruvate labeling is produced in intracellular space. Given very low typical ALT activity in plasma (20-60 IU/L) (32, 33) , alanine conversion to pyruvate in extracellular space is expected to be small, barring cellular ALT released to the blood steam due to hepatocellular damage or necrotic cell death. The contribution of ethanol-induced elevation of ALT activity (34) to the hyperpolarized 13 C-alanine measurement was also negligible, because no sign of [1- 13 C]lactate was detected in the blood serum from the high-resolution NMR analysis (Fig. 4, Supporting Table S1 ). Second, the chemical exchange between pyruvate and lactate must be sufficiently fast for the measured signals to reflect the endogenous pool sizes. Studies consistently support that the isotopic exchanges between alanine, pyruvate, and lactate are rapid compared with the time scale of hyperpolarized 13 C studies (35) (36) (37) . Finally, the cytosolic pH must remain stable and not perturbed by the excessive alanine infusion.
Effects of Ethanol Metabolism in 13 C-Bicarbonate Production
Another notable ethanol-induced metabolic change was decreased 13 C-bicarbonate production, which may result from changes in the mitochondrial redox (see Fig. 5 ), assuming that no metabolic disturbance was induced from the baseline alanine injection. In mitochondria, the production of acetate from acetaldehyde leads to increased levels of acetyl-coenzyme A, inhibiting pyruvate dehydrogenase (PDH) (30) . Furthermore, increased generation of mitochondrial NADH also reduces the activity of the TCA cycle, and the acetyl-coenzyme A is diverted to fatty acid synthesis, which also leads to a disruption in gluconeogenesis. However, the use of bicarbonate labeling as a biomarker for mitochondrial redox requires further investigation.
Limitations and Potential Improvements
Following the injection of hyperpolarized [1- 13 C]alanine, the production of 13 C-labeled pyruvate, lactate, and bicarbonate is limited by the activities of the alanineserine-cysteine transporter (24) and the intracellular enzymes ALT, lactate dehydrogenase, and PDH. In the rat studies presented here, the measured pyruvate, lactate, and bicarbonate signals were dominated by the injected alanine (Table 1) . Considering the superior ALT activity in liver and kidney compared with other organs, the feasibility of the proposed method is likely limited to studies of liver and kidney.
In addition to enzyme and transporter activities, endogenous metabolite pool sizes are also important contributing factors to the generation of 13 C-labeled products (34) . Under typical conditions, the observed 13 C-labeled pyruvate and bicarbonate peaks are about 1/10 that of 13 C-lactate. Although 13 C-bicarbonate production is restricted by PDH activity, the small 13 C-pyruvate signal is likely limited by the small intrinsic pyruvate pool size in cytoplasm. Such limitations were not investigated in this study, and additional experiments with varying dosages and/or concentrations of hyperpolarized 13 C-alanine would be needed to optimize the SNR and reliability of the redox measurements, especially for the localized redox information obtainable with spectroscopic imaging. One potential way to augment the observed pyruvate and lactate signals might be to coinject unlabeled pyruvate and/or lactate to increase the corresponding metabolic pool sizes (38 Potential loss of 13 C-lactate to the blood stream is another limitation in the use of hyperpolarized 13 C-alanine as a redox marker, because lactate can be readily exported out of the cells (Fig. 1) . The serum analysis using 1 H NMR spectroscopy, however, suggests that the 13 C-lactate export to extracellular space is negligible within the 1-min observation time window, where most hyperpolarized 13 C signals are detected. Higher polarization and/or faster build-up might be achieved by further optimization in alanine polarization. For example, the relatively low polarization (14% at 40 s post-dissolution) could be due to the multistep sample insertion procedure of the SPINlab system (14 steps by default), which may induce crystallization in the sample (rather than a glass).
Potential Applications
Hepatic redox changes are associated with multiple liver pathologies including hepatocellular carcinoma (39), nonalcoholic steatohepatitis (40, 41) , viral hepatitis C (42), inflammation (43) , fibrosis (44) , and hepatic encephalopathy (45) . Moreover, hepatic redox measure is a promising indicator of acute hepatotoxicity resulted from drug-induced reactive oxygen species (46) . Acute and chronic ethanol metabolism results in reduced gluconeogenesis and impaired fatty acid oxidation, with the diversion of carbons into fats driving increased triglyceride production, fatty infiltrations, and ultimately liver damage and failure (47) . Moreover, increased levels of mitochondrial NADH result in the increased production of reactive oxygen species, further contributing to liver deterioration.
However, applying hyperpolarized [1-
13 C]alanine to liver diseases with elevated serum ALT require careful interpretation of 13 C-lactate/ 13 C-pyruvate ratio due to the increased extracellular alanine conversion to pyruvate, possibly resulting in nonnegligible contribution of extracellular balance of pyruvate and lactate to the measured 13 C-lactate/ 13 C-pyruvate. Thus, tools to assess cellular redox noninvasively could be very important in early detection of metabolic abnormalities, monitoring the degree of disease progression, and the response of therapeutics in liver, and [1- 13 C]alanine is a hyperpolarizable substrate that may meet this challenge. Although alanine is known to have positive regulatory roles in energy supplies (e.g., promoting blood glucose regulation and preventing nighttime hypoglycemia for type 2 diabetes), excessive alanine injection may have detrimental effects, including strong cellular depolarization, suppression of insulin secretion, and inhibitory effects on gluconeogenesis. The toxicity and allowable dosage of hyperpolarized alanine require further examination.
In conclusion, we showed the feasibility of using hyperpolarized [1- 13 C]alanine as a substrate to measure in vivo cytosolic redox in rat liver, and demonstrated a significant increase of the 13 C-lactate/ 13 C-pyruvate ratio after liver redox modulation using ethanol. The coincident reduction of 13 C-bicarbonate with ethanol may reflect changes in mitochondrial redox state.
